Toggle Offcanvas
...
 
Tolvaptan Tenders

Tolvaptan Tenders

View Tolvaptan tenders, RFPs and contracts. Bid on readily available Tolvaptan tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Tolvaptan tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Tolvaptan.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Tolvaptan market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Tolvaptan tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

71 Live Notices for Tolvaptan Tenders

Showing 1 to 20

Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By Means Of An Open House Model To The Active Ingredient Tolvaptan (Atc Code: C03Xa01)
country Germany
posting date10 Feb 2025
deadline31 May 2025
Supply of Medicine and Medical / Surgical equipments : Tolvaptan Tablet 15mg\nTolvaptan Tablet 15mg\nEach tablet to contain Tolvaptan 15mg.\nNote: The shelf life of the product should be minimum\nof 24 months etc .
country Sri Lanka
posting date05 Feb 2025
deadline10 Feb 2025
Cca. 6Pwpjk5 Framework Agreement, With Several Companies, Establishing The Conditions For The Supply Of Medicines Used In The Health Centres Of The Andalusian Health Service.
country Spain
posting date31 Jan 2025
deadline14 Feb 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: C03Xa01)
country Germany
posting date04 Jul 2024
deadline31 Aug 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21)
country Germany
posting date04 Jul 2024
deadline31 Aug 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21)
country Germany
posting date04 Jul 2024
deadline31 Aug 2026
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
country Germany
posting date14 Jun 2024
deadline01 Jun 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tolvaptan (C03Xa01) As Part Of A So-Called Open House Model.
country Germany
posting date21 Mar 2024
deadline28 Feb 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tolvaptan (G04Bx21) As Part Of A So-Called Open House Model.
country Germany
posting date21 Mar 2024
deadline28 Feb 2026
Medicines Containing The Active Ingredient Tolvaptan (Atc: C03Xa01)
country Germany
posting date19 Jul 2023
deadline30 Jun 2025
Medicines Containing The Active Ingredient Tolvaptan (G04Bx21)
country Germany
posting date19 Jul 2023
deadline30 Jun 2025
Medicines Containing The Active Ingredient Tolvaptan (Atc: C03Xa01)
country Germany
posting date17 Jul 2023
deadline30 Jun 2025
Medicines Containing The Active Ingredient Tolvaptan (G04Bx21)
country Germany
posting date17 Jul 2023
deadline30 Jun 2025
Open House Drug Discount Agreements Tolvaptan, Atc C03Xa01 And/Or Atc G04Bx21
country Germany
posting date20 Jun 2023
deadline05 Jun 2025
Open House Drug Discount Agreements Tolvaptan, Atc C03Xa01 And/Or Atc G04Bx21
country Germany
posting date19 Jun 2023
deadline05 Jun 2025
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: C03Xa01)
country Germany
posting date06 Jul 2024
deadline31 Aug 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21)
country Germany
posting date06 Jul 2024
deadline31 Aug 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: C03Xa01)
country Germany
posting date05 Jul 2024
deadline31 Aug 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: G04Bx21)
country Germany
posting date05 Jul 2024
deadline31 Aug 2026
Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Tolvaptan (Atc Code: C03Xa01)
country Germany
posting date05 Jul 2024
deadline31 Aug 2026

Share Share this page